Procardia and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Procardia (nifedipine), especially for people who are female, 50-59 old, have been taking the drug for 10+ years also take Lasix, and have Febrile neutropenia.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Procardia. It is created by eHealthMe based on reports of 14,828 people who have side effects when taking Procardia from the FDA, and is updated regularly.

What is Procardia?

Procardia has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 15,151 Procardia users. Check the latest studies of Procardia.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 2,008 drugs and 1,973 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

On Jul, 06, 2026

14,828 people reported to have side effects when taking Procardia.
Among them, 22 people (0.15%) have Dermatitis - atopic.

Could Procardia cause Dermatitis - atopic?

Among these 22 people:

How long have people been on Procardia when they have Dermatitis - atopic? *

What is the gender of people who have Dermatitis - atopic when taking Procardia? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Dermatitis - atopic when taking Procardia? *

What are other drugs people take besides Procardia? *

What are other side effects people have besides Dermatitis - atopic? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 54.55%
Thrombocytopenia (decrease of platelets in blood): 12 people, 54.55%
Swallowing Difficulty: 12 people, 54.55%
Head Injury: 11 people, 50.00%
Faecal Incontinence (a lack of control over passing stool): 11 people, 50.00%
Ear Pain: 10 people, 45.45%
Nausea (feeling of having an urge to vomit): 10 people, 45.45%
Dizziness: 9 people, 40.91%
Weakness: 9 people, 40.91%
Neuropathy Peripheral (surface nerve damage): 9 people, 40.91%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 22.73%
Febrile Neutropenia (fever with reduced white blood cells): 5 people, 22.73%
High Blood Cholesterol: 4 people, 18.18%
Diabetes: 4 people, 18.18%
Weight Loss: 2 people, 9.09%
Joint Pain: 2 people, 9.09%
Ill-Defined Disorder: 2 people, 9.09%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 9.09%
Diabetic Nephropathy (diabetic kidney disease): 2 people, 9.09%
Back Pain: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Procardia and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Procardia:

Procardia (15,151 reports)

Browse all side effects of Procardia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (2,008 drugs)

Browse all the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,973 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Procardia) and Procardia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.